Company Filing History:
7 out of 145 
1 out of 141 Years Active: 2018-2023
Title: Thomas Wechsler: Innovator in Genome Engineering
Introduction
Thomas Wechsler is a prominent inventor based in Richmond, CA (US). He has made significant contributions to the field of genome engineering, with a focus on developing methods for treating genetic disorders. With a total of 7 patents to his name, Wechsler's work has the potential to impact the lives of many individuals suffering from various diseases.
Latest Patents
Among his latest patents, Wechsler has developed a method for making and using mammalian liver cells for treating hemophilia or lysosomal storage disorders. This patent discloses methods and compositions for targeted, nuclease-mediated insertion of transgene sequences into the genome of a cell. Additionally, he has created methods and compositions for genome engineering, which involve the insertion of transgene sequences encoding proteins that are aberrantly expressed in diseases or disorders, such as lysosomal storage diseases.
Career Highlights
Throughout his career, Thomas Wechsler has worked with notable companies, including Sangamo Therapeutics, Inc. and Sigma-Aldrich Co. LLC. His experience in these organizations has allowed him to refine his expertise in genetic engineering and therapeutic development.
Collaborations
Wechsler has collaborated with esteemed colleagues, including Jeffrey C. Miller and David Paschon. These partnerships have further enhanced his research and innovation in the field.
Conclusion
Thomas Wechsler's contributions to genome engineering and his innovative patents position him as a key figure in the advancement of treatments for genetic disorders. His work continues to inspire future developments in the field.